-+ 0.00%
-+ 0.00%
-+ 0.00%

Kala Bio Q4 EPS $(1.74) Beats $(2.28) Estimate

Benzinga·03/31/2025 12:16:25
Listen to the news
Kala Bio (NASDAQ:KALA) reported quarterly losses of $(1.74) per share which beat the analyst consensus estimate of $(2.28) by 23.68 percent. This is a 45.28 percent increase over losses of $(3.18) per share from the same period last year.